Evidence map›Paper›PMID 39964121›Full record

Trial reportAIDS care2025

Comparing PrEP use among men who have sex with men with a recent incarceration history.

Gabriel G Edwards, Brandon Moghanian, Cathy J Reback, Katrina M Schrode, Robert E Weiss, Nina T Harawa

Abstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in AIDS care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gabriel G EdwardsDepartment of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Brandon MoghanianDepartment of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Cathy J RebackCenter for HIV Identification, Prevention, and Treatment Services, University of California, Los Angeles, CA, USA.
Katrina M SchrodeDepartment of Psychiatry, Charles R Drew University, Los Angeles, CA, USA.
Robert E WeissCenter for HIV Identification, Prevention, and Treatment Services, University of California, Los Angeles, CA, USA.
Nina T HarawaDepartment of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

Funding

Sustaining Faculty Development & Community EngagementS21MD000103 · NIMHD · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI CARLISLE, DAVID M · 2001 to 2015
$73.9M
UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Sung-Jae Lee · 1997 to 2026
$53.5M
NCATS NIH HHS UL1 TR000124NIMHD NIH HHS S21 MD000103NIMH NIH HHS P30 MH058107
6 · The paper itself

Abstract

This study compares pre-exposure prophylaxis (PrEP) use among men who have sex with men (MSM) with a recent history of incarceration across various factors known to contribute to HIV transmission risk, including sexual identity, race/ethnicity, sexual activity, incarceration history, injection drug use, and internalized homophobia. We analyzed baseline lifetime PrEP use (yes or no) of 170 male-identifying participants enrolled in a randomized-controlled trial in Los Angeles County between 2019 and 2022. Using logistic regression, we assessed the association of PrEP with sexual identity, socio-demographics, and potential confounders. Compared to gay/same-gender loving-identified participants, straight/heterosexual-identified (aOR = 0.10, CI = 0.02-0.49) and bi-pansexual-identified (0.39, 0.16-0.95) participants had reduced odds of PrEP use. Black/African American-identified participants had lower odds (0.15, 0.03-0.78) of PrEP use than White-identified participants. Participants reporting 3+ years cumulative lifetime incarceration had lower odds (0.28, 0.09-0.87) of PrEP use than participants reporting <6 months. Controlling for internalized homophobia rendered differences among sexual identity groups non-significant. A similar effect was not observed for race/ethnicity and lifetime incarceration. Internalized homophobia was an important driver of PrEP use differences among MSM along the lines of sexual identity but not along the lines of race/ethnicity or cumulative incarceration.

Indexed as

HIV InfectionsHomosexuality, MalePre-Exposure ProphylaxisPrisonersAdultHumansIncarcerationLos AngelesMaleMiddle AgedSexual Behaviorincarcerationinternalized homophobiamen who have sex with menPrEPsexual identity

Identifiers

PMID39964121
PMCPMC12048272

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.